HomeNewsBusinessCompaniesAPI facility to boost revenue by 5-10%: Nectar Lifesciences

API facility to boost revenue by 5-10%: Nectar Lifesciences

Nectar Lifesciences has received European approval for its Cephalosporin APIs manufacturing facility at Derabassi in Punjab. Dinesh Dua, chief executive director at Nectar Lifesciences, in an interview to CNBC-TV18, said the API manufacturing facility is likely to boost the company’s revenues by 5-10%.

October 14, 2011 / 16:19 IST
Story continues below Advertisement

Your browser doesn't support HTML5 video.

Nectar Lifesciences has received European approval for its Cephalosporin APIs manufacturing facility at Derabassi in Punjab. Dinesh Dua, chief executive director at Nectar Lifesciences, in an interview to CNBC-TV18, said the API manufacturing facility in Punjab is likely to boost the company

first published: Oct 14, 2011 02:29 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!